Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Chin-Tu Chen
University of Chicago, Department: Radiation Diagnostic/oncology
Should you be removed from our database? Contact us at [email protected]. Read more below.
EDDA Technology
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr Chen conducts research in, and holds several patents on molecular imaging. EDDA Technology, Inc. is engaged in the field of medical imaging and analysis. They are involved in developing a series of next generation computer assisted radiology and surgery solutions to the entire patient care management cycle, by supporting early cancer detection and diagnosis of diseases as well as enhancing efficiency and precision in treatment planning, management and follow-up. The current study addresses the incidence of CRC, early methods of detection/monitoring and prevention/eradication of colorectal adenomatous polyps and their precursors which are needed, prior to polyp malignancy transformation (M-T). Unfortunately the most effective drugs at inhibiting adenomatous polyp formation/growth – nonsteroidal anti-inflammatory drugs (NSAIDs) – are poorly targeted and limited by dose-dependent adverse GI/cardiac/hepatic sequelae. Since this study uses nanotheranostic techniques, imaging approaches and applications will be employed, among other techniques.
Nanotheranostics for Early Colorectal Cancer Detection and Treatment
To reduce the incidence of colorectal cancer, early in situ methods of detection/monitoring and prevention/eradication of colorectal adenomatous polyps and their precursors are urgently needed, prior to polyp malignancy transformation (M-T). Unfortunately the most effective drugs at inhibiting adenomatous polyp formation and growth - nonsteroidal anti-inflammatory drugs (NSAIDs) - are poorly targeted and limited by dose-dependent adverse GI/cardiac/hepatic sequelae. In this work we develop and evaluate novel, orally administered, polyp-targeting nanoplatforms that serve both as contrast agents and traceable drug delivery platforms, to provide a means for the prevention, detection, staging, and non-surgical eradication of adenomatous polyps prior to their M-T.
Filed on April 18, 2013.
Tell us what you know about Chin-Tu Chen's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Chin-Tu Chen”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Chin-Tu Chen | University of Chicago | Conflict of Interest | EnDepth Vision System, LLC | Value cannot be readily determined |
| Chin-Tu Chen | University of Chicago | Conflict of Interest | Medical Sinica Corporation | Value cannot be readily determined |
| Chin-Tu Chen | University of Chicago | Conflict of Interest | Medical Sinica Corporation | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.